Platelet Rubicon drives thrombosis independent of autophagy

In this issue of Blood Advances, Alfar et al 1 have identified an unexpected, autophagy-independent function for the protein Rubicon (RUN domain Beclin-1-interacting and cysteine-rich-containing protein) in platelets, demonstrating that it is a key promoter of arterial thrombosis.Rubicon is widely recognized in nucleated cells as a negative regulator that actively inhibits autophagy, a critical housekeeping process during which cellular components are recycled. 2,3The new findings, based on mice with a platelet-specific deletion of Rubicon (Rubcn -/-), reveal that its role in platelets is different, promoting thrombosis without significantly altering the activation-induced recycling mechanisms.This work fundamentally changes our understanding of how Rubicon controls platelet biology and offers a new pathway to explore in the treatment of cardiovascular disease.

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-02-24
DOI
https://doi.org/10.1182/bloodadvances.2025019011
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Platelet Rubicon drives thrombosis independent of autophagy

Nirav Dhanesha
Blood Advances
Autophagy in Disease and Therapy
article

Platelet Rubicon drives thrombosis independent of autophagy

Nirav Dhanesha
article en

Abstract

In this issue of Blood Advances, Alfar et al 1 have identified an unexpected, autophagy-independent function for the protein Rubicon (RUN domain Beclin-1-interacting and cysteine-rich-containing protein) in platelets, demonstrating that it is a key promoter of arterial thrombosis.Rubicon is widely recognized in nucleated cells as a negative regulator that actively inhibits autophagy, a critical housekeeping process during which cellular components are recycled. 2,3The new findings, based on mice with a platelet-specific deletion of Rubicon (Rubcn -/-), reveal that its role in platelets is different, promoting thrombosis without significantly altering the activation-induced recycling mechanisms.This work fundamentally changes our understanding of how Rubicon controls platelet biology and offers a new pathway to explore in the treatment of cardiovascular disease.

Blood AdvancesVol. 10(4)
Louisiana State University Health Sciences Center Shreveport (US)
Openalex Percentile: Top 45%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.